Immunotherapy

Next-generation NK cell-based immunotherapies for hard-to-treat cancers

Associate Professor Fernando Guimaraes is an internationally recognised leader in cancer immunotherapy and natural killer (NK) cell biology. Based at The University of Queensland, he leads innovative research focused on developing next-generation NK cell-based immunotherapies for hard-to-treat cancers, including sarcomas and neuroblastoma.

Dr Jasmine Kaur

RESEARCH IN IMMUNOTHERAPY
@ GRIFFITH UNIVERSITY
QUEENSLAND, AUSTRALIA

Scroll to top